Vedolizumab
- Part D specialty tier in 86% of formularies (2026Q3)
- Biologic
- ENTYVIO
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Vedolizumab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Refrigerate ENTYVIO unopened vials, prefilled syringes, and prefilled pens at 2°C to 8°C (36° to 46°F).
- Freezing
- Do not freeze
Label statement
Do not freeze ENTYVIO vial, prefilled syringe, or prefilled pen.
- Room temperature
- up to 7 days at or below 25°C (77°F)
Label statement
If needed, the ENTYVIO prefilled syringe or ENTYVIO PEN can be left out of the refrigerator in the original package at room temperature up to 25°C (77°F) for up to 7 days (for example, when traveling).
- Room temperature
- up to 7 days
Label statement
Do not use ENTYVIO prefilled syringe or ENTYVIO PEN if left out of the refrigerator for more than 7 days.
- Room temperature
- up to 7 days at or below 25°C (77°F)
Label statement
Your prefilled pen can be left in its box at room temperature up to 77°F (25°C) for up to 7 days (for example, when traveling).
- Room temperature
- up to 7 days
Label statement
Do not use the prefilled pen if it is left out of the refrigerator for more than 7 days.
- Room temperature
- up to 7 days
Label statement
Throw away the prefilled pen in a FDA-cleared sharps disposal container if it has been left out of the refrigerator for more than 7 days, frozen, or left in direct sunlight.
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Retain in original package to protect from light until the time of use.
- Shaking
- Do not shake
Label statement
Do not shake the ENTYVIO prefilled syringe or ENTYVIO PEN.
- Travel
- Stated
Label statement
If needed, the ENTYVIO prefilled syringe or ENTYVIO PEN can be left out of the refrigerator in the original package at room temperature up to 25°C (77°F) for up to 7 days (for example, when traveling).
- Travel
- Stated
Label statement
Your prefilled pen can be left in its box at room temperature up to 77°F (25°C) for up to 7 days (for example, when traveling).
All storage statements on the label (14)
- Refrigerate ENTYVIO unopened vials, prefilled syringes, and prefilled pens at 2°C to 8°C (36° to 46°F).
- If needed, the ENTYVIO prefilled syringe or ENTYVIO PEN can be left out of the refrigerator in the original package at room temperature up to 25°C (77°F) for up to 7 days (for example, when traveling).
- Do not use ENTYVIO prefilled syringe or ENTYVIO PEN if left out of the refrigerator for more than 7 days.
- Do not freeze ENTYVIO vial, prefilled syringe, or prefilled pen.
- Do not use ENTYVIO vial, prefilled syringe, or prefilled pen if it has been frozen.
- Do not shake the ENTYVIO prefilled syringe or ENTYVIO PEN.
- Retain in original package to protect from light until the time of use.
- Storing ENTYVIO Store your prefilled pen in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Your prefilled pen can be left in its box at room temperature up to 77°F (25°C) for up to 7 days (for example, when traveling).
- Do not use the prefilled pen if it is left out of the refrigerator for more than 7 days.
- Do not freeze the prefilled pen.
- Throw away the prefilled pen in a FDA-cleared sharps disposal container if it has been left out of the refrigerator for more than 7 days, frozen, or left in direct sunlight.
- Remove the ENTYVIO PEN box from the refrigerator Take 1 prefilled pen box from the refrigerator and check the expiration date on the box (see Figure A ).
- Do not use the prefilled pen if the expiration date on the box has passed.
FDA label version 26, effective April 29, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.